Highbridge Capital Management LLC has filed its 13F form on November 08, 2024 for Q3 2024 where it was disclosed a total value porftolio of $333 Million distributed in 339 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Liberty Broadband Corp with a value of $61.9M, Hess Corp with a value of $61.3M, Amedisys Inc with a value of $31.2M, Hashi Corp, Inc. with a value of $28.9M, and Nuvei Corp with a value of $26.4M.
Examining the 13F form we can see an decrease of $133M in the current position value, from $466M to 333M .
Highbridge Capital Management LLC is based out at New York, NY
Below you can find more details about Highbridge Capital Management LLC portfolio as well as his latest detailed transactions.
Portfolio value
$333 Million
Communication Services: $82.3 Million
Energy: $61.3 Million
Technology: $60.5 Million
Healthcare: $46.5 Million
Consumer Defensive: $33.7 Million
Consumer Cyclical: $32.1 Million
Utilities: $13.6 Million
ETFs: $981,000
Other: $882,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 0.42%
Perceptive Cap Solutions Cor
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 9.35%
Perception Capital Corp Iii
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.85%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 74.11%
-
$0
0.0% of portfolio
-
Q4 2023
Added 10.71%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 12.23%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 66.61%
-
$0
0.0% of portfolio
-
Q2 2024
New
Qomolangma Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2023
Added 50.68%
-
$0
0.0% of portfolio
-
Q1 2024
Added 3.15%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 1.92%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.06%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 20.0%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
Silexion Therapeutics Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 17.09%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 9.93%
-
$0
0.0% of portfolio
-
Q3 2024
Added 33.33%
$386M
$7,000
0.0% of portfolio
575
Q1 2021
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 1.02%
-
$0
0.0% of portfolio
-
Q3 2024
Added 19.89%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
Oak Woods Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2023
New
Conduit Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 2.55%
Calidi Biotherapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.27%
Cactus Acquisition Corp 1 Lt
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 4.76%
-
$0
0.0% of portfolio
-
Q1 2024
Added 13.2%
-
$0
0.0% of portfolio
-
Q3 2024
Added 27.7%
Bukit Jalil Gbl Acquisition
-
$0
0.0% of portfolio
-
Q1 2024
Added 0.04%
Bukit Jalil Gbl Acquisition
-
$0
0.0% of portfolio
-
Q3 2023
New
Brightspring Health Svcs Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 75.92%
Bridger Aerospace Grp Hldgs
-
$0
0.0% of portfolio
-
Q3 2024
Added 8.5%
Brand Engagement Network Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 23.26%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Added 2.19%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
$949K
$0
0.0% of portfolio
40,541
Q3 2024
Reduced 27.01%
-
$0
0.0% of portfolio
-
Q3 2024
Added 33.33%
Cantor Equity Partners Inc
-
$0
0.0% of portfolio
-
Q3 2024
New